New PET scan for better brain tumor care
Part of Brain & nervous system, Cancer clinical trials.
This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with a brain tumor
- Your doctor recommends an amino acid PET scan for reasons like planning surgery, radiation, or checking if a tumor is growing or responding to treatment
- You are able to give consent for the study, or have someone who can do it for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a brain PET scan using a medicine called FMISO can help show how active certain brain tumors are. It mainly aims to see if the scan is practical and useful in planning care for people with suspected or known brain tumors.
This study looks at how well a specific PET scan (using a tracer called [18F]FET) can help doctors diagnose brain tumors, check how well treatment is working, or spot tumors that come back. Researchers will analyze images you may have already had or will have as part of your regular care.
This study checks how well an FDOPA PET scan can identify and describe a specific type of brain tumor at the beginning. Results may help doctors decide on the best next steps for diagnosis and treatment planning.
This study uses a special PET/MRI scan with an amino acid tracer to better see if brain tumors (either starting in the brain or spreading from elsewhere) have come back after treatment. The scan may help doctors tell the difference between tumor growth and treatment-related changes.
This trial tests a new imaging method (68Ga-DOTA-mPNE PET/CT) to see if it can help detect cancers. It's for people who haven't had chemotherapy or radiation yet and will have a biopsy or surgery.
This study tests a special imaging agent called fluoroethyltyrosine (FET) to see if it can better detect brain tumors on PET scans. It may help doctors decide if a tumor has come back after treatment or better guide initial biopsy or surgery.
Hear when a new Malignant Brain Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.